Clinical Trial Update: Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212) [Phase 3]

View source ↗

Summary

Phase 3 trial update on mometasone furoate/formoterol fumarate (Dulera) inhaler for persistent asthma in adolescents and adults; results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• DULERA (MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE)

Snippet

Sponsor: Organon and Co | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2013-07-29